4//SEC Filing
Lyon Lyman Max Jr 4
Accession 0001132072-09-000308
CIK 0000894158other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 1:58 PM ET
Size
5.9 KB
Accession
0001132072-09-000308
Insider Transaction Report
Form 4
Lyon Lyman Max Jr
DirectorCEO & President
Transactions
- Award
Option to Purchase Common Stock
2009-06-26+400,000→ 400,000 totalExercise: $0.38Exp: 2019-06-26→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]100,000 of the stock options vested upon the grant. The remaining 300,000 options will vest monthly in equal monthly installments over a period of 36 months.
Documents
Issuer
ADEONA PHARMACEUTICALS, INC.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001469184
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 1:58 PM ET
- Size
- 5.9 KB